Found: 9
Select item for more details and to access through your institution.
Association of peripheral blood DNA methylation levels with Alzheimer's disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052477
- By:
- Publication type:
- Article
P3‐120: DNA METHYLATION DYNAMICS IN ALZHEIMER'S DISEASE: DEVELOPMENT OF BIOMARKERS AND NOVEL DRUG TARGETS USING ADNI EPIGENETIC DATA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1113, doi. 10.1016/j.jalz.2018.06.1477
- By:
- Publication type:
- Article
DNA METHYLATION DYNAMICS IN ALZHEIMER’S DISEASE DIAGNOSIS AND PROGRESSION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P297, doi. 10.1016/j.jalz.2017.06.209
- By:
- Publication type:
- Article
Comparison of exposure response relationship of atrasentan between North American and Asian populations.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 4, p. 545, doi. 10.1111/dom.12851
- By:
- Publication type:
- Article
Association of peripheral blood DNA methylation level with Alzheimer's disease progression.
- Published in:
- Clinical Epigenetics, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13148-021-01179-2
- By:
- Publication type:
- Article
Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.
- Published in:
- Clinical Epigenetics, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13148-020-00864-y
- By:
- Publication type:
- Article
Integrative analysis of DNA methylation and gene expression identifies genes associated with biological aging in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12354
- By:
- Publication type:
- Article
Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0198296
- By:
- Publication type:
- Article
Selective IL-23 Inhibition by Risankizumab Modulates the Molecular Profile in the Colon and Ileum of Patients With Active Crohn's Disease: Results From a Randomised Phase II Biopsy Sub-study.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 10, p. 1170, doi. 10.1093/ecco-jcc/jjy099
- By:
- Publication type:
- Article